Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial

被引：0
|
作者：
Nils Venhoff
Wolfgang A. Schmidt
Peter Lamprecht
Hans-Peter Tony
Christine App
Christian Sieder
Carolin Legeler
Claudia Jentzsch
Jens Thiel
机构：
[1] Klinik für Rheumatologie und Klinische Immunologie,Department Innere Medizin
[2] Vaskulitiszentrum Freiburg,Department of Immunology, Hepatology & Dermatology
[3] Universitätsklinikum Freiburg,undefined
[4] Immanuel Krankenhaus Berlin,undefined
[5] Klinik für Innere Medizin,undefined
[6] Abteilung Rheumatologie und Klinische Immunologie in Berlin-Buch,undefined
[7] Universität zu Lübeck,undefined
[8] Klinik für Rheumatologie und klinische Immunologie,undefined
[9] Medizinische Klinik II,undefined
[10] Universitätsklinik,undefined
[11] Rheumatology/Immunology,undefined
[12] Novartis Pharma GmbH,undefined
[13] Novartis Pharma AG,undefined
来源：
Trials | / 22卷
关键词：
Giant cell arteritis; Secukinumab; Phase II trial; Placebo; Double-blind;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial
    Venhoff, Nils
    Schmidt, Wolfgang A.
    Lamprecht, Peter
    Tony, Hans-Peter
    App, Christine
    Sieder, Christian
    Legeler, Carolin
    Jentzsch, Claudia
    Thiel, Jens
    TRIALS, 2021, 22 (01)
  • [2] A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
    Schmidt, Wolfgang A.
    Dasgupta, Bhaskar
    Sloane, Jennifer
    Giannelou, Angeliki
    Xu, Yuqing
    Unizony, Sebastian H.
    Mackie, Sarah L.
    Gonzalez-Gay, Miguel A.
    Spiera, Robert
    Warrington, Kenneth J.
    Villiger, Peter M.
    Nivens, Michael C.
    Akinlade, Bolanle
    Lin, Yong
    Buttgereit, Frank
    Stone, John H.
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [3] A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
    Wolfgang A. Schmidt
    Bhaskar Dasgupta
    Jennifer Sloane
    Angeliki Giannelou
    Yuqing Xu
    Sebastian H. Unizony
    Sarah L. Mackie
    Miguel A. Gonzalez-Gay
    Robert Spiera
    Kenneth J. Warrington
    Peter M. Villiger
    Michael C. Nivens
    Bolanle Akinlade
    Yong Lin
    Frank Buttgereit
    John H. Stone
    Arthritis Research & Therapy, 25
  • [4] The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
    Lena Kreis
    Christian Dejaco
    Wolfgang Andreas Schmidt
    Robert Németh
    Nils Venhoff
    Valentin Sebastian Schäfer
    Trials, 25
  • [5] The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis-study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
    Kreis, Lena
    Dejaco, Christian
    Schmidt, Wolfgang Andreas
    Nemeth, Robert
    Venhoff, Nils
    Schaefer, Valentin Sebastian
    TRIALS, 2024, 25 (01)
  • [6] A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
    Schmidt, Wolfgang A.
    Dasgupta, Bhaskar
    Luqmani, Raashid
    Unizony, Sebastian H.
    Blockmans, Daniel
    Lai, Zhihong
    Kurrasch, Regina H.
    Lazic, Ivana
    Brown, Kurt
    Rao, Ravi
    RHEUMATOLOGY AND THERAPY, 2020, 7 (04) : 793 - 810
  • [7] A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Giant Cell Arteritis
    Wolfgang A. Schmidt
    Bhaskar Dasgupta
    Raashid Luqmani
    Sebastian H. Unizony
    Daniel Blockmans
    Zhihong Lai
    Regina H. Kurrasch
    Ivana Lazic
    Kurt Brown
    Ravi Rao
    Rheumatology and Therapy, 2020, 7 : 793 - 810
  • [8] One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
    Genovese, Mark C.
    Durez, Patrick
    Richards, Hanno B.
    Supronik, Jerzy
    Dokoupilova, Eva
    Aelion, Jacob A.
    Lee, Sang-Heon
    Codding, Christine E.
    Kellner, Herbert
    Ikawa, Takashi
    Hugot, Sophie
    Ligozio, Gregory
    Mpofu, Shephard
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (03) : 414 - 421
  • [9] A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)
    Spiera, RF
    Mitnick, HJ
    Kupersmith, M
    Richmond, M
    Spiera, H
    Peterson, MGE
    Paget, SA
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (05) : 495 - 501
  • [10] Efficacy of topiramate in migraine patients. Randomized, double-blind, placebo-controlled group
    Cho, SJ
    Lee, S
    Don, IH
    Yang, HD
    CEPHALALGIA, 2005, 25 (10) : 935 - 935
12345